We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
OBJECTIVE The purpose of this study was to create reference range nomograms of the axial fetal neck circumference (FNC) and fetal neck area (FNA) throughout gestation. METHODS This prospective cross-sectional study involved pregnant patients between 14 and 40 weeks' gestation. Inclusion criteria consisted of well-established dates (confirmed by early(More)
7339 Background: This phase I/II trial is being conducted to test the safety, toxicity, and initial efficacy of this novel regimen of celecoxib plus carboplatin/gemcitabine for advanced NSCLC. Celecoxib is a selective COX-2 inhibitor with strong inhibitory effects on NSCLC cell lines. Since NSCLC often overexpresses COX-2, and celecoxib's toxicity does not(More)
  • 1